Alan E. Walts
Executive Chairman
Genetics
Artax biopharma
Spain
Biography
Dr. Walts has served as the Executive Chairman since February 2017 and has been an Advisor to Artax since July, 2015. In addition to serving as Executive Chairman of Artax, Alan is also Executive Chairman of Aura Biosciences, a Director of X4 Pharmaceuticals and a Director of Arrakis Therapeutics. Alan is a US-based Venture Partner with Advent Life Sciences, a Business Advisor to Henri Termeer, and an advisor to various life science companies. Alan has over 25 years of industry experience in venture capital, business development, research and development, and general management at Genzyme Corporation. Prior to leaving Genzyme in 2013, Alan most recently managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures). Alan received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the executive Program for Management Development at Harvard Business School.
Research Interest
genetics
